Dr. Mario Boccadoro is Professor of Hematology and Oncology and currently works as the Director of Hematology in the Oncology Division at the University of Torino, a position to which he was appointed in 2000. Dr. Boccadoro’s clinical trials have focused on transplantation (autologous and allogeneic) and on the use of novel drugs. His work spans a wide subject area within Multiple Myeloma (MM) including: the effect of high doses versus conventional therapy, the role of prognostic factors, immunotherapy, molecular alterations and minimal residual disease, the role of mini-allograft and establishing clinical protocols with the use of new drugs.
Dr. Boccadoro completed his scientific and clinical training at the Free University of Brussels and at the Cancer Center in Tucson, AZ, USA. He specialized in Hematology at the University of Bologna and also worked at the San Giovanni Battista Hospital in Turin.
Dr. Boccadoro is the founder of the Italian Myeloma Study Group, the first research consortium in Italy, and has authored or co-authored more than 350 publications in peer-reviewed journals. In recognition of his influential work, he was the recipient of the prestigious Sixth Annual Robert A. Kyle Lifetime Achievement Award in 2008. He is also a member of the steering committee for the Multiple Myeloma Hub.